Chenggui Wang

机构：Wenzhou Medical University, Sir Run Run Shaw Hospital, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Zhejiang Lab, Precision Spine (United States), Yancheng Third People's Hospital, Sichuan Academy of Traditional Chinese Medicine, Zhejiang Mariculture Research Institute, Zhejiang University · ORCID：0000-0002-0512-784X

发表论文 99 篇 · 总被引 6081 次 · h-index 39

代表论文

• PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma (2023 · Frontiers in Immunology · 被引 63)
• Anlotinib potentiates anti‐PD1 immunotherapy via transferrin receptor‐dependent CD8 + T‐cell infiltration in hepatocellular carcinoma (2024 · Clinical and Translational Medicine · 被引 52)
• Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury (2023 · Journal of Controlled Release · 被引 47)
• Partial reprogramming strategy for intervertebral disc rejuvenation by activating energy switch (2022 · Aging Cell · 被引 44)
• Mechanics-electro-adaptive multifunctional bioactive nanocomposites hydrogel for inducing spinal cord regeneration (2022 · Chemical Engineering Journal · 被引 35)
• An esterase-responsive ibuprofen nano-micelle pre-modified embryo derived nucleus pulposus progenitor cells promote the regeneration of intervertebral disc degeneration (2022 · Bioactive Materials · 被引 31)